LANCRIX

Paclitaxel, ≥99%

Catalog No. 365857

Identification
SynonymsTaxol
CAS No.33069-62-4
M.F.

C47H51NO14

M.W.853.91
Beilstein No.1420457
MDL No.MFCD00869953
PubChem Substance ID24900422
Derived from Semisynthetic from Taxus baccate
Technical Data
AppearanceWhite powder
Specific Rotation (°)-49° to -55°
Assay≥99%
SolubilityEthanol and DMSO
Storage2-8℃
ApplicationAntitumor agent; promotes and stabilizes tubulin polymerization, causing cell cycle arrest. Induces autocatalytic activation of caspase-10 in CCRF-HSB-2 cells, triggering apoptosis.
Safety Data
SymbolGHS08GHS07GHS05
Hazard StatementsH315-H317-H318-H334-H335-H341-H361
Precautionary StatementsP261-P280-P305 + P351 + P338-P342 + P311
Hazard SymbolsXn
Risk StatementsR37/38-41-42/43-62-68
Safety StatementsS22-26-36/37/39-45
WGK Germany3
RTECSDA8340700
Reference

Merck Index 12 7117.

McGuire et al (1989) Ann.Intern.Med. 111 273. PMID: 2569287.

Rowinsky et al (1990) Natl.Cancer Inst. 82 1247. PMID: 1973737.

Rao et al (1999) J.Biol.Chem. 274 37990. PMID: 10608867.

Park et al (2004) J.Biol.Chem. 279 51057. PMID: 15452117.

Availability: Ships in 1-3 days

For research use only.

Inquire

(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject 365857, Paclitaxel, ≥99%, 33069-62-4
*Message
*Code If it’s not clear, please click on the picture to change one.